[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Faculdade de Ciências Médicas de Minas Gerais\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":119},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,57,88],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":35,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":51,"leadSponsor":53,"locationsCount":56},"100622848","peripheral-autonomic-block-bap-plus-transversus-abdominis-plane-block-tap-for-postoperative-analgesia-after-minimally-invasive-left-sided-colorectal-resection-baptap-100622848",false,"NCT07388953","Peripheral Autonomic Block (BAP) Plus Transversus Abdominis Plane Block (TAP) for Postoperative Analgesia After Minimally Invasive Left-Sided Colorectal Resection (BAPTAP)","Peripheral Autonomic Block (BAP) Plus Transversus Abdominis Plane Block (TAP) for Postoperative Analgesia After Minimally Invasive Left-Sided Colorectal Resection (BAPTAP): A Randomized, Controlled, Double-Blind Trial","BAPTAP","Inclusion Criteria:\n\n* Elective laparoscopic left-sided colorectal resection\n* ASA physical status I-II\n* Ability to understand the study and sign informed consent\n\nExclusion Criteria:\n\n* Known allergy to study medications (e.g., local anesthetics)\n* Coagulation disorders\n* Pregnancy\n* Inability to understand or provide consent\n* Chronic pain on opioid therapy\n* BMI \\> 35 kg\u002Fm²","ALL","18 Years","80 Years",{"count":21,"type":22},140,"ESTIMATED","INTERVENTIONAL",[25],"NA","Effective postoperative pain management is essential for enhanced recovery after laparoscopic colorectal surgery. This randomized, controlled, double-blind trial will compare conventional postoperative analgesia (intravenous medications plus surgical wound infiltration) with a locoregional strategy combining a peripheral autonomic block (inferior mesenteric and superior hypogastric plexuses) and a transversus abdominis plane (TAP) block. We hypothesize that the combined strategy (BAPTAP) reduces pain intensity and opioid consumption in the first 48 hours after Left-Sided Colorectal Resection.",[28,29,30,31,32,33,34],"Colorectal Cancer","Colorectal Surgery","Anesthesia","Autonomic Nerve Block","Transversus Abdominis Plane (TAP) Block","Pain Management","Post Operative Analgesia",[36,37,38,39,40,41,42,43,44],"colorectal surgery","Postoperative Pain","Peripheral Autonomic Block","Superior Hypogastric Plexus","Inferior Mesenteric Plexus","TAP Block","ERAS","Ropivacaine","Opioid-sparing Analgesia","RECRUITING","2026-02-12",{"date":48,"type":49},"2026-02-13","ACTUAL",{"date":46,"type":49},{"date":52,"type":22},"2027-07-05",{"name":54,"class":55},"Faculdade de Ciências Médicas de Minas Gerais","OTHER",1,{"id":58,"slug":59,"hasResults":11,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":17,"minAge":18,"maxAge":66,"enrollmentInfo":67,"targetDuration":69,"studyType":70,"phases":4,"briefSummary":71,"conditions":72,"keywords":76,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":85,"leadSponsor":87,"locationsCount":56},"100578596","analysis-of-facial-expressions-for-pain-recognition-in-fibromyalgia-using-artificial-intelligence-and-biomarkers-100578596","NCT06813352","Analysis of Facial Expressions for Pain Recognition in Fibromyalgia: Using Artificial Intelligence and Biomarkers","Analysis of Facial Expressions for Pain Recognition: Using Artificial Intelligence and Biomarkers as a Pain Diagnostic Tool in Fibromyalgia, a Pilot Study","Fibromyalgia","Inclusion Criteria:\n\n* The inclusion criteria are patients with no diagnosed cognitive deficit and who are willing to take part in the study.\n\nExclusion Criteria:\n\n* Exclusion criteria are patients who use medication that can affect anxiety or depression or inability to understand the instructions.",true,"65 Years",{"count":68,"type":22},122,"1 Day","OBSERVATIONAL","Fibromyalgia (FM) is a chronic musculoskeletal pain syndrome with characteristics of generalized body pain, low pain threshold, tenderness and stiffness in muscles, tendons and joints. The assessment of pain in this condition is a challenge due to its subjective nature. A promising approach to assessing pain intensity is facial expression analysis, which can serve as an objective indicator. In addition, research seeks to identify molecular molecular markers to quantify pain. However, the lack of a standardized system has made it difficult to identify reliable markers. In summary, the search for objective methods of assessing pain in fibromyalgia is essential in order to develop more effective more effective treatments. Facial expression analysis and the investigation of molecular markers are promising ways of quantifying pain intensity more accurately and intensity of pain more accurately and reliably in fibromyalgia.",[73,74,75],"Fibromyalgia (FM)","Pain","Catastrophizing Pain",[63,77,78,79,80],"Artificial intelligence","Molecular biomarkers","Catastrophism","Facial expression","2025-11-17",{"date":83,"type":49},"2025-11-19",{"date":81,"type":49},{"date":86,"type":22},"2026-09-01",{"name":54,"class":55},{"id":89,"slug":90,"hasResults":11,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":4,"eligibilityCriteria":94,"healthyVolunteers":11,"sex":17,"minAge":95,"maxAge":4,"enrollmentInfo":96,"targetDuration":4,"studyType":23,"phases":98,"briefSummary":99,"conditions":100,"keywords":102,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":56},"100582586","efficacy-and-safety-of-gonioscopy-assisted-transluminal-trabeculotomy-in-patients-with-primary-open-angle-glaucoma-and-cataract-100582586","NCT06865235","Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.","Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract - a Randomized Clinical Trial","Inclusion Criteria:\n\n* Patients aged 40 years or older,\n* Previously included in the glaucoma departments of the participating institutions,\n* Indication for cataract surgery, diagnosed by clinical examination with visual acuity (VA) equal to or worse than 20\u002F40,\n* Primary Open Angle Glaucoma (POAG), determined by the presence of typical visual field (VF) defects and\u002For by the aspect of the optic nerve observed at fundoscopy or retinography (increased vertical optical excavation with thinning of the neural rhyme, asymmetry of the cup\u002Fdisc ratio greater than 0.2, localized loss (\"notch\") or defect in the retinal nerve fiber layer (\"Hoyt\")).\n* APIC classification with amplitude greater\u002Fequal to 2 and pigmentation less than 4 on gonioscopy.\n* Intraocular pressure (IOP) less than or equal to 25 mmHg before washout of hypotensive eye drops.\n* IOP between 22 and 30 mmHg after washout of hypotensive eye drops or with a history of IOP greater than or equal to 21 mmHg in more than one previous care described in the medical record.\n\nExclusion Criteria:\n\nPatients who have any of the following situations:\n\n* Severe glaucoma, determined according to the Hoddap-Parrish-Anderson criteria;\n* Axial diameter greater than 26 mm or less than 21.00 mm;\n* Endothelial count less than 1500 cc;\n* Pachymetry less than 480 or greater than 600 microns;\n* Patients undergoing some type of intraocular surgery or laser procedure in the preoperative period and\u002For after these procedures in the postoperative period;\n* Those who present some important per-operative complication during the study.\n* With high risk of progression, the so-called rapid progressors, who are patients with high IOPs even with the use of many medications, regardless of the severity of the nerve injury.","40 Years",{"count":97,"type":22},90,[25],"Prospective, randomized, , double-blind, clinical trial, comparing the variation of intraocular pressure (IOP) of patients with mild or moderate primary open-angle glaucoma (OAG) and cataract divided into three groups. All study participants should be treated for the pathology with one or more hypotensive medications or, regardless of the number of drugs, when IOP is greater than 20 mmHg and less than 26 mmHg. The two-year follow-up should also compare the reduction in the number of medications used, reoperation rate, adverse effects, visual acuity, endothelial loss, induction of astigmatism, variation in IOP according to axial diameter of the eye, anterior chamber and age, in addition to the existence of change in the quality of life of patients in the postoperative period",[101],"Open Angle Glaucoma (OAG)",[103,104,105,106,107,108,109,110],"Open angle glaucoma","Cataract","OAG","Goniotomy assisted transluminal trabeculotomy","GATT","trabeculotomy","Goniotomy","hemi-gatt","2025-03-05",{"date":113,"type":49},"2025-03-07",{"date":115,"type":49},"2024-05-07",{"date":117,"type":22},"2028-02",{"name":54,"class":55},""]